ACTRN12621001307897招募中未知
Assessment of antibody response to COVID-19 vaccination in people with solid tumours
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •1. Planning to receive the COVID-19 vaccine or
- •received one dose of COVID-19 vaccine or
- •within 3 months of completion of COVID-19 vaccination (received two doses of the vaccine)
- •2. Recipients of either the Pfizer, AstraZeneca or Moderna COVID-19 vaccines
- •3. Cancer patient cohort: confirmed solid tumour malignancy and:
- •a.Receiving systemic cancer treatment: cytotoxic therapy, immunotherapy or targeted therapy within two weeks of at least one of the vaccine doses.
- •b.Targeted therapy includes and is not limited to tyrosine kinase inhibitors e.g. imatinib, cabozantinib, pazopanib, gefitinib, osimertinib; CDK4/6 inhibitors; BRAF/MEK inhibitors
- •c.Patients receiving hormonal therapy alone will not be eligible for the study.
排除标准
- •1.Beyond 3 months following receipt of second dose of COVID-19 vaccination.
- •2.Past laboratory confirmed diagnosis of COVID-19 infection (such as nasopharyngeal RT-PCR swab). Routine screening for COVID-19 infection beyond requirements of the local health authority is not required.
- •3.Concurrent diagnosis of active haematological malignancy.
研究者
相似试验
招募中
4 期
Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune diseasePsoriatic arthritisAnkylosing spondylitisCOVID-19Inflammatory bowel diseaseInflammatory and Immune System - Autoimmune diseasesOral and Gastrointestinal - Crohn's diseaseOral and Gastrointestinal - Inflammatory bowel diseaseMusculoskeletal - Other muscular and skeletal disordersInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersInflammatory and Immune System - Rheumatoid arthritisCrohn's DiseaseRheumatoid arthritisUlcerative ColitisACTRN12621000661875Dr Ai Tran100
尚未招募
不适用
COVID-19 vaccination of vulnerable populations (COVULPOP)COVID-19 vaccine responseCOVID-19Inflammatory and Immune System - Normal development and function of the immune systemRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12621001492842Prof Katie Flanagan40
已完成
不适用
To study if BCG vaccinated individuals have enhanced COVID-19 antibodies after COVID-19 vaccination.CTRI/2022/10/046542I70
招募中
不适用
Evaluation of the immune response against COVID-19 in pediatric Cancer patients after vaccinatioeed for vaccination against COVID-19C91C92Lymphoid leukaemiaMyeloid leukaemiaDRKS00025254Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität100
尚未招募
不适用
COVID-19 VaccinAtion in patients with chronic Kidney disease in New Zealand (C-VAK NZ study)Kidney TransplantDialysisCovid-19Renal and Urogenital - Kidney diseaseInfection - Other infectious diseasesACTRN12621000460808Auckland District Health Board600